(Q40087201)

17 September 2017

1 reference

title

Comparison of labetalol with other anti-hypertensive drugs (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

9 August 2023

author name string

B. N. Prichard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124265

9 August 2023

D. A. Richards

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124265

9 August 2023

language of work or name

English

0 references

publication date

1 June 1982

1 reference

PMC publication ID

1401845

full work available at URL

17 September 2017

https://europepmc.org/articles/PMC1401845

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124265

https://europepmc.org/articles/PMC1401845?pdf=render

9 August 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124265

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1982.tb01888.x

9 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1982.tb01888.x/fullpdf

9 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

British Journal of Clinical Pharmacology

9 August 2023

published in

1 reference

17 September 2017

13

1 reference

17 September 2017

1 Suppl

1 reference

17 September 2017

41S-47S

1 reference

Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison

17 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Mechanism of the antihypertensive action of beta-adrenergic blocking drugs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Labetalol in resistant hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Haemodynamic effects of long-term oral labetalol

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Rate of onset of hypotensive effect of oral labetalol

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Labetalol infusion in acute myocardial infarction with systemic hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Long-term treatment of hypertension with labetalol

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Treatment of severe hypertension by repeated bolus injections of labetalol

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

A comparative study of methyldopa and labetalol in the treatment of hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Intravenous labetalol in hypertensive patients given by fast and slow injection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Modulation of noradrenergic transmission by the presynaptic alpha-inhibitory feedback process in the rat heart [proceedings]

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Labetalol in hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Clinical pharmacology of labetalol

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Rapid onset of action of oral labetalol in severe hypertension

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Labetalol and bendrofluazide: comparison of their antihypertensive effects

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Labetalol and pindolol in the treatment of hypertension: a comparative study

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Alpha and beta adrenergic blockade in hypertension.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Anti-hypertensive action, time of onset and effects on carbohydrate metabolism of labetalol

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Controlled comparison of labetalol and propranolol in the management of severe hypertension

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Experience with labetalol in hypertension.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Emergency treatment of severe hypertension with intravenous labetalol

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401845

Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.

17 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01888.X

Sympathomimetic amine infusion after beta-adrenoceptor and parasympathetic blockade [proceedings]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01888.X

Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension

21 January 2018

1 reference

12 December 2020

Intravenous labetalol in hypertensive emergency

1 reference

12 December 2020

Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension

1 reference

12 December 2020

Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects

1 reference

12 December 2020

Circulatory effects of noradrenaline and adrenaline before and after labetalol

1 reference

12 December 2020

Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension

1 reference

12 December 2020

Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol

1 reference

12 December 2020

Double-blind trial of labetalol

1 reference

12 December 2020

Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo

1 reference

12 December 2020

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

Treatment of severe hypertension by repeated bolus injections of labetalol

9 August 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

Labetalol in resistant hypertension.

9 August 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

Labetalol infusion in acute myocardial infarction with systemic hypertension

9 August 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension

9 August 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings

9 August 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

Labetalol in long-term treatment of hypertension

9 August 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

Long-term treatment of hypertension with labetalol

9 August 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

A comparative study of methyldopa and labetalol in the treatment of hypertension

9 August 2023

46

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

Cardiovascular effects of labetalol during halothane anaesthesia

9 August 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1982.TB01888.X

9 August 2023

Identifiers

1 reference

17 September 2017

1 reference

PMC publication ID

1401845

17 September 2017

1 reference

PMC publication ID

1401845